Cost Control Strategies for Rare Disease Clinical Trials
Cost Control Strategies for Rare Disease Clinical Trials Balancing Innovation and Efficiency: Cost Control in Rare Disease Trials The High Cost Landscape of Rare Disease Trials Rare disease clinical trials often require intensive resources, customized procedures, and complex logistics, making them significantly more expensive per patient than conventional trials. According to a Tufts CSDD analysis,…
Read More “Cost Control Strategies for Rare Disease Clinical Trials” »